Presseportal.ch - APR Applied Pharma Research s.a.https://www.presseportal.ch/de/nr/100068008?langid=2Presseportal.ch: APR Applied Pharma Research s.a. (Newsroom)de-denews aktuell schweiz AGhttps://www.presseportal.ch/images/logos/logo-ch-250.jpgPresseportal.ch - APR Applied Pharma Research s.a.https://www.presseportal.ch/de/nr/100068008?langid=2info@newsaktuell.ch (presseportal.ch)Sat, 07 Mar 2026 16:29:49 +0100Wed, 04 Dec 2019 12:22:48 +0100APR Applied Pharma Research s.a.6FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis BullosaAPR Applied Pharma Research s.a.: Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation ...https://www.presseportal.ch/de/pm/100068008/100837955?langid=2Wed, 04 Dec 2019 12:22:48 +0100https://www.presseportal.ch/de/pm/100068008/100837955?langid=2 APR Applied Pharma Research s.a. [Newsroom]
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation ... Lesen Sie hier weiter...

]]>Wirtschaftinfo@newsaktuell.ch (presseportal.ch)APR Applied Pharma Research s.a.29th EWMA Conference: Latest Clinical Data on Nexodyn® AOS Demonstrating Higher Healing Performance in Chronic Leg Ulcers Presented by Applied Pharma ResearchAPR Applied Pharma Research s.a.: Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa (APR) presented at the recent 29th conference of the European Wound Management Association (EWMA) in Göteborg, the results of a clinical study confirming Nexodyn® AcidOxidizing ...https://www.presseportal.ch/de/pm/100068008/100829031?langid=2Tue, 11 Jun 2019 12:00:44 +0200https://www.presseportal.ch/de/pm/100068008/100829031?langid=2 APR Applied Pharma Research s.a. [Newsroom]
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa (APR) presented at the recent 29th conference of the European Wound Management Association (EWMA) in Göteborg, the results of a clinical study confirming Nexodyn® AcidOxidizing ... Lesen Sie hier weiter...

]]>Wirtschaftinfo@newsaktuell.ch (presseportal.ch)APR Applied Pharma Research s.a.